Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database

Ronen Arnon, Rachel Annunziato, Tamir Miloh, Melissa Wasserstein, Hiroshi Sogawa, Monique Wilson, Frederick Suchy, Nanda Kerkar

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11 467 children in the UNOS database, 125 (1.1%) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4%) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4% and 90.4%, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.

Original languageEnglish (US)
Pages (from-to)400-405
Number of pages6
JournalPediatric Transplantation
Issue number4
StatePublished - Jun 2011
Externally publishedYes


  • complications of liver transplantation
  • congenital liver disease
  • graft survival
  • liver transplantation
  • pediatric transplantation
  • tyrosinemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation


Dive into the research topics of 'Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database'. Together they form a unique fingerprint.

Cite this